Nigel Bundred
Overview
Explore the profile of Nigel Bundred including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harvie M, Livingstone K, McMulllan D, Pegington M, Lombardelli C, Adams J, et al.
Breast Cancer Res Treat
. 2024 May;
207(1):203-212.
PMID: 38758461
Purpose: A combined body weight loss and upper body/arm exercise programme is a potential strategy for managing Breast cancer related lymphoedema (BCRL), but there is limited data on the best...
2.
Potter S, Fairhurst K, Cowan K, Vincent S, Lewis I, Cutress R, et al.
Breast Cancer Res Treat
. 2022 Nov;
197(1):39-49.
PMID: 36319906
Purpose: A James Lind Alliance priority setting partnership was developed to identify research priorities in breast cancer surgery from individuals with lived experience, at high genetic risk of breast cancer,...
3.
Bundred N, Porta N, Brunt A, Cramer A, Hanby A, Shaaban A, et al.
Clin Cancer Res
. 2022 Feb;
28(7):1323-1334.
PMID: 35165099
Purpose: EPHOS-B aimed to determine whether perioperative anti-HER2 therapy inhibited proliferation and/or increased apoptosis in HER2-positive breast cancer. Patients And Methods: This randomized phase II, two-part, multicenter trial included newly...
4.
Harvie M, Pegington M, Howell S, Bundred N, Foden P, Adams J, et al.
Br J Cancer
. 2021 Dec;
126(8):1157-1167.
PMID: 34912072
Background: Excess adiposity at diagnosis and weight gain during chemotherapy is associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of intermittent energy restriction (IER) vs continuous energy...
5.
Bundred N, Todd C, Riches K, Keeley V
Br J Cancer
. 2021 Mar;
124(9):1608-1609.
PMID: 33731857
No abstract available.
6.
Bundred J, Michael S, Bowers S, Barnes N, Jauhari Y, Plant D, et al.
Eur J Surg Oncol
. 2020 Sep;
46(12):2185-2194.
PMID: 32907774
Background: No consensus exists regarding adequacy of margins after mastectomy. To determine if pathological margin proximity is associated with local (LR) or distant recurrence after mastectomy for early invasive breast...
7.
Bundred N, Foden P, Todd C, Morris J, Watterson D, Purushotham A, et al.
Br J Cancer
. 2020 May;
123(1):17-25.
PMID: 32362658
Background: Lymphoedema develops after axillary clearance (ANC) in 25% of patients. This prospective, multi-centre study compared multi-frequency bioimpedance spectroscopy (BIS) with arm volume measurement to: (1) determine which test has...
8.
Harvie M, Pegington M, Bundred N, Campbell A, Belcher J, Howell S, et al.
Br J Cancer
. 2020 Jan;
122(6):925-926.
PMID: 31932752
No abstract available.
9.
Harvie M, Pegington M, McMullan D, Bundred N, Livingstone K, Campbell A, et al.
Br J Cancer
. 2019 Aug;
121(6):443-454.
PMID: 31366999
Background: Breast cancer diagnosis may be a teachable moment for lifestyle behaviour change and to prevent adjuvant therapy associated weight gain. We assessed the acceptability and effectiveness of two weight...
10.
Timbrell S, Al-Himdani S, Shaw O, Tan K, Morris J, Bundred N
Ann Surg Oncol
. 2016 Nov;
24(4):1071-1076.
PMID: 27837296
Background: The incidence of ductal carcinoma in situ (DCIS) is increasing with the use of screening mammography, and approximately 30% of all women diagnosed with DCIS are treated by mastectomy....